ECG Effects of Dofetilide, Moxifloxacin, Dofetilide+Mexiletine, Dofetilide+Lidocaine and Moxifloxacin+Diltiazem 1.0.0

File: (1,042,882 bytes)

EGREFID	RANDID	SEX	AGE	HGHT	WGHT	SYSBP	DIABP	RACE	ETHNIC	ARMCD	VISIT	TRTA	DOF	LIDO	MEXI	MOXI	MOXI.M2	DILT	TPT	BASELINE	RR	PR	QT	QRS	JTPEAK	TPEAKTEND	TPEAKTPEAKP	ERD_30	LRD_30	Twave_amplitude	Twave_asymmetry	Twave_flatness
39BF8219-C83A-4121-926F-2BC730FBE127	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	-0.5	Y	1124	166	420	72	263	85	NA	52	28	727.7845179035	0.1929824501	0.5300399661
905B0D27-D4E7-4812-8895-48E2B58B6757	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	-0.5	Y	1150	173	420	75	261	84	NA	50	29	733.9128652054	0.2037037015	0.5382068753
EB1CD234-82BC-4AD4-A7A8-15EC0FFFA6BF	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	-0.5	Y	1134	169	421	74	260	87	NA	54	30	699.2899747933	0.2363636345	0.5367771983
46869F3C-5097-412B-9B99-30E3FB4670C5	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	1.5	N	1063	168	398	76	234	88	NA	55	30	612.590936922	0.2321428508	0.5149975419
6092BAC1-5069-4937-B7E5-3EED96308E2C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	1.5	N	1018	168	397	74	236	87	NA	65	36	576.7663206689	0.2962962985	0.5162849426
F1ACF2BB-C68A-4026-B3D8-0CFFED9D29FB	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	1.5	N	1044	166	398	76	234	88	NA	63	37	576.7774771523	0.2363636345	0.5098620653
234B7892-E996-4CCD-A4B5-C6D1E67A4C4E	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2	N	1017	168	390	69	235	86	NA	52	33	626.6630259438	0.2321428508	0.4949404895
559E8009-F4A8-4495-A1E5-951AFC04D957	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2	N	988	167	389	70	235	84	NA	52	28	656.7525929846	0.2800000012	0.4923144579
65986F03-9A19-4FAF-BF3B-0C7A64236DF1	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2	N	1122	171	391	77	229	85	NA	52	30	653.7431401684	0.2307692319	0.4943392873
C188D335-151F-453C-B1D2-A207A9B6B894	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2.5	N	1098	170	393	67	243	83	NA	51	30	680.6025244861	0.2222222239	0.5019184351
CBC5F7F0-2AF3-44CD-9854-208048B9C621	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2.5	N	1059	170	393	68	241	84	NA	51	28	677.4705926778	0.2452830225	0.5013114214
F560D070-1A7B-4CC5-B92A-D86FF54BA927	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2.5	N	1052	168	393	68	241	84	NA	50	28	707.9294971651	0.2075471729	0.4958449602
480D519A-756A-4A1F-AEE1-4C7BCA4C663B	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	3	N	1107	164	390	65	242	83	NA	48	26	839.0385648623	0.1923076957	0.4900842309
DA775214-A3D7-4221-B76E-49D8CCF93E8B	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	3	N	1096	162	389	66	239	84	NA	48	28	809.2042050135	0.1960784346	0.4899588525
EEE37BE1-B0AC-4BAA-8BD9-A5B474D2FC4E	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	3	N	1099	164	388	66	239	83	NA	47	28	840.5167140785	0.1960784346	0.4855643809
54CF5774-3205-4FBE-B018-C94581CD204B	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	6.5	N	989	159	390	69	229	92	NA	65	41	550.1821113835	0.2456140369	0.4902038276
D6652388-CCC2-43D3-8D94-FD3408B14E61	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	6.5	N	1015	161	390	71	229	90	NA	64	41	565.4771710434	0.2068965584	0.499338299
DF0BF6D6-B1C5-4984-BD8E-FEBF8DBA975F	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	6.5	N	988	158	390	71	229	90	NA	63	39	568.4239573448	0.2321428508	0.4896709025
112D3767-4F93-4245-B31D-30505B7E8FCF	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7	N	1004	161	392	70	235	87	NA	56	35	559.2555138794	0.25	0.5023309588
6497AA8A-6FE0-44EE-8963-48AFC8FB3AD4	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7	N	1053	163	392	69	232	91	NA	58	37	532.8455206688	0.2456140369	0.4991591275
914CF47E-EB90-4E95-AFA3-FA77CED1CB14	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7	N	987	166	393	69	233	91	NA	57	35	550.0464740896	0.2592592537	0.4997153878
61E62526-91F0-47E4-A3C9-11AFAAF27AE6	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7.5	N	980	161	390	70	233	87	NA	55	34	565.4491649393	0.2321428508	0.5002769828
6C52824B-A5FE-4C74-AEEC-E2621A6A58FD	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7.5	N	1031	162	395	70	237	88	NA	54	33	577.1156608148	0.2068965584	0.501023531
BC3A08DE-FF17-4C11-B285-76A36D212530	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7.5	N	1010	165	390	70	234	86	NA	54	33	596.5643262137	0.2456140369	0.5019412637
9DBB43F0-6016-4153-8CD6-A675C147DEDC	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	8	N	1021	161	387	71	230	86	NA	53	30	678.5828227941	0.200000003	0.4916217625
C572DBF0-28F2-41DA-A1A1-0D35065F38D9	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	8	N	999	162	388	71	230	87	NA	59	38	639.6676052192	0.2037037015	0.4888770282
D3F83CAF-FCF0-415B-90D2-41C2ABF68232	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	8	N	1040	163	390	72	231	87	NA	52	34	643.9732191903	0.1785714328	0.488887459
08D58E4C-2910-45B6-B83A-DC4BD6DC987C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12	N	950	161	388	69	231	88	NA	60	38	643.740985995	0.2884615362	0.4883843958
9221F9F4-B330-4476-97E8-FAF6B859C70C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12	N	957	163	387	69	233	85	NA	61	33	660.5506025851	0.269230783	0.4905666709
DE6B0375-C2D9-4197-A08B-24EB2EB67946	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12	N	966	161	388	68	234	86	NA	60	37	641.1557961952	0.2909090817	0.4859688282
07AD6C75-E4B7-4F6B-B264-F9FA5DB4F8B7	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12.5	N	1014	164	400	71	241	88	NA	54	30	677.4754002715	0.2830188572	0.5121054053
38BA92FE-B1FC-4FFA-BA09-A02EFDE08583	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12.5	N	1058	166	406	69	244	93	NA	56	32	646.0555877907	0.2909090817	0.5242316127
850D5757-E1FE-48F3-B6C1-071F44DB4591	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12.5	N	997	161	406	68	243	95	NA	72	40	564.447384074	0.4363636374	0.5274394751
7BA1168C-7E82-4CD1-81CB-681AC872C7F3	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13	N	1024	164	397	69	238	90	NA	54	33	619.6665229896	0.301886797	0.5068323016
BCE77330-7743-4085-8559-37643E933732	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13	N	1011	164	393	69	234	90	NA	53	33	631.9404364453	0.2641509473	0.5001778007
CDA2E533-2356-4E2D-A3D3-6AB8C675F1DD	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13	N	1015	163	397	69	239	89	NA	56	33	613.1436774966	0.3090909123	0.5065523982
6C8F2C47-0515-42AD-9380-0B4D671DA46B	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13.5	N	957	164	387	69	228	90	NA	61	36	636.5503785852	0.2407407463	0.4889936745
E4132895-C759-46E7-8548-45AFC15F6DA8	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13.5	N	962	160	387	70	230	87	NA	61	34	644.6263062272	0.2830188572	0.4910051823
E78631D3-3FBF-4BEB-891E-9AFE63BDF4C7	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13.5	N	979	159	387	71	227	89	NA	61	37	628.7288955112	0.2641509473	0.4836788476
16CBB888-B48D-42B8-9CBB-1803C1BD5EE9	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	24	N	1006	162	403	72	241	90	NA	69	39	615.2062618839	0.2962962985	0.5088142157
1B4B27D4-681D-4E34-86C1-AF65C39613CF	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	24	N	967	160	401	73	238	90	NA	67	36	625.6870801451	0.3653846085	0.509357512
CD7CCA99-0CE3-40D2-93E6-31CC10794FEB	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-1-DOSING	Placebo	NA	NA	NA	NA	NA	NA	24	N	993	163	400	71	242	87	NA	64	34	667.5089195899	0.314814806	0.5083899498
5F0DC88F-C7CD-4ADD-B6C1-BD0337F55649	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	1163	171	425	85	251	89	NA	55	31	671.3069480349	0.200000003	0.5227858424
DD05EF17-9E2C-41D5-A168-845F2486CC4C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	1170	172	425	87	251	87	NA	55	30	678.5840687475	0.1960784346	0.5149123669
DE64871C-F5FE-4593-8489-C31F16EEFA16	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	1103	167	424	82	254	88	NA	54	31	674.3827495631	0.2156862766	0.5294930339
1C955752-B7DD-4E1C-98A6-E23F3A3CEC9B	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	1.5	N	1093	168	400	78	237	85	NA	52	30	682.3978250685	0.2222222239	0.4964733422
68F7201A-7FDE-4399-9128-B61498D474E8	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	1.5	N	1064	167	399	78	236	85	NA	52	31	676.2367508955	0.2264150977	0.4979141355
CD26EBE4-4948-4F48-8003-41F5C80FEBA0	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	1.5	N	1041	168	399	78	235	86	NA	54	32	638.4367328684	0.2407407463	0.4913150668
507692B6-F147-491E-B44C-6B99AE296C3D	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	2	N	1070	174	394	68	240	86	NA	52	31	643.7872842009	0.2156862766	0.4868902564
B54C80ED-4A93-4926-9305-B254B3A7FA48	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	2	N	1112	175	394	77	229	88	NA	53	32	617.8299921412	0.2115384638	0.4865270257
CAA1DEC9-E3E4-40BF-B294-46901E7D05C2	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	2	N	1073	174	397	78	234	85	NA	54	30	638.0313902369	0.2307692319	0.4870822728
125B35E9-E09E-4BD6-B292-23F680E2857B	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	2.5	N	1160	174	402	79	236	87	NA	52	31	660.4008099728	0.1886792481	0.5036334991
D53A1831-768E-431D-9E3A-F92206909168	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	2.5	N	1127	171	401	77	238	86	NA	54	32	647.662567278	0.2264150977	0.4977416098
EE4FA714-1181-458B-9A77-4973846B1268	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	2.5	N	1055	170	400	77	236	87	NA	54	30	659.2449981084	0.2399999946	0.4952157438
3323B832-7DF4-4AF4-80A2-0EE01BC8F6B1	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	3	N	1075	165	394	74	233	87	NA	53	29	700.4498927251	0.1960784346	0.4799371958
395BD7EC-71A1-4EC1-83C7-249278A255DE	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	3	N	1052	163	392	74	232	86	NA	57	31	694.7446693862	0.1960784346	0.4820716381
B42915A2-CBFF-421C-AF9C-61AA6612D3BB	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	3	N	1080	167	388	73	230	85	NA	59	34	688.5678274891	0.1923076957	0.4823459685
3A5B8340-0AAD-491D-B732-B8C8B3AFFBAF	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1160	NA	NA	NA	NA	NA	6.5	N	1149	163	437	73	260	104	NA	82	49	526.3585487357	0.6071428657	0.5770122409
84C9A5C9-C231-4E8F-95E7-30A5A3EFC9C8	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1160	NA	NA	NA	NA	NA	6.5	N	1070	160	443	73	244	126	NA	97	52	470.2093078433	0.6379310489	0.5860958695
9D482501-1B82-4B32-9E00-D4D9F82BF851	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1160	NA	NA	NA	NA	NA	6.5	N	969	160	435	72	239	124	NA	88	51	456.5027300942	0.4677419364	0.5739159584
2BCD1FDF-CF6A-4DD4-8B1E-54683F191C54	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1160	NA	NA	NA	NA	NA	7	N	1094	167	424	72	254	98	NA	81	41	572.4441022827	0.4909090996	0.556964457
305BA481-22E7-4E14-A8E8-8E19E9078DEA	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1160	NA	NA	NA	NA	NA	7	N	933	163	427	71	245	111	NA	89	56	474.111352302	0.7407407165	0.561950922
3DDAEB69-9AB0-4EE9-99A2-CE544DED5E82	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1160	NA	NA	NA	NA	NA	7	N	1042	165	427	71	250	106	NA	67	38	541.1046977949	0.5454545617	0.5610799789
0C074C97-F2E7-4716-A970-E41E90468379	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1120	NA	NA	NA	NA	NA	7.5	N	1116	167	432	73	251	108	NA	86	42	539.1107701002	0.5090909004	0.5698065758
6787100A-37DC-41C3-8D99-C063A3D72E66	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1120	NA	NA	NA	NA	NA	7.5	N	1097	167	430	73	254	103	NA	84	43	542.6386646204	0.4912280738	0.5695958734
EB82E369-5EDD-4D95-B0BB-6B6C2C5835B7	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1120	NA	NA	NA	NA	NA	7.5	N	1094	167	430	73	260	97	NA	83	41	560.84692969	0.4482758641	0.5686966181
479DC5A9-72CC-4EA8-93E0-364758908797	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1070	NA	NA	NA	NA	NA	8	N	1075	166	430	75	247	108	NA	80	48	530.2951727642	0.3928571343	0.5541411638
4A9880DE-B989-4BD0-876E-0C2F245707A2	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1070	NA	NA	NA	NA	NA	8	N	1038	161	425	75	240	110	NA	82	47	517.3324529235	0.4067796469	0.5520953536
6D4484BD-FA60-4EB6-82AE-B5CE83D8DB8B	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1070	NA	NA	NA	NA	NA	8	N	1089	165	429	75	247	107	NA	79	46	539.4875742282	0.3859649003	0.5602016449
3121F0E5-5117-4604-A777-03C3D8A165FA	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1680	NA	NA	NA	NA	NA	12	N	1025	162	448	71	260	117	NA	87	54	489.8621193241	0.5423728824	0.5879015923
31BB0223-C382-4393-94CE-BCF0089DE8D9	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1680	NA	NA	NA	NA	NA	12	N	1018	164	446	71	259	116	NA	103	51	490.4352348208	0.5964912176	0.5757172704
F6170E50-646F-49B4-9D5C-BE245D916A3F	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1680	NA	NA	NA	NA	NA	12	N	1021	163	443	72	268	103	NA	93	46	506.4951035402	0.6000000238	0.5834070444
442F2EF9-7A56-4AD6-9DFE-A8BBEDD0D60C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1570	NA	NA	NA	NA	NA	12.5	N	993	161	439	71	251	117	NA	99	49	498.1721700406	0.6363636255	0.5772388577
BF845807-363D-4A91-AFA2-4177DD96517C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1570	NA	NA	NA	NA	NA	12.5	N	1006	161	440	71	259	110	NA	100	46	505.9890310478	0.6206896305	0.5836571455
E23213AD-9535-45DF-AB69-5326C1651215	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1570	NA	NA	NA	NA	NA	12.5	N	1009	161	447	72	260	115	NA	102	57	471.3084358359	0.7678571343	0.5892847776
3F4EBE84-0CF3-4DD8-91F8-957D160594DF	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1620	NA	NA	NA	NA	NA	13	N	1030	165	445	71	259	115	NA	92	58	499.5228538042	0.6206896305	0.5876902938
9E39935B-1BF3-435E-B468-25D3256777E9	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1620	NA	NA	NA	NA	NA	13	N	1048	165	444	71	261	112	NA	98	55	496.5162780261	0.6666666865	0.5803356767
BDBAD607-6813-42AB-9FDC-91CD1907D39F	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1620	NA	NA	NA	NA	NA	13	N	1034	164	442	72	253	117	NA	93	54	510.6225331681	0.7017543912	0.5852968097
5ECC8182-4CF4-41DF-99CB-D036F45CD605	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1430	NA	NA	NA	NA	NA	13.5	N	1013	165	426	71	253	102	NA	88	46	559.3562995596	0.553571403	0.5503824353
B4F28AF3-AD1E-4932-961E-D6ADD03CFE8B	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1430	NA	NA	NA	NA	NA	13.5	N	976	163	421	71	250	100	NA	85	45	572.9217930156	0.5660377145	0.5480290651
EAB1565C-FE53-4D80-AD6C-7D9EE456D05D	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	1430	NA	NA	NA	NA	NA	13.5	N	983	162	426	71	253	102	NA	88	43	573.303453527	0.6037735939	0.5572606921
18C06031-912A-4F2F-8CE4-E986DD99EFEC	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	24	N	1098	166	425	82	252	91	NA	59	33	603.2225681242	0.3076923192	0.5351366401
86E518B8-5756-4657-9BE0-06DDEABA0014	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	24	N	1141	165	425	85	242	98	NA	60	36	566.2342500877	0.3703703582	0.5423698425
D8AB70FF-2B62-4F8B-AB5F-A9003A4F9861	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-2-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	24	N	1107	169	425	85	247	93	NA	59	32	608.8556232668	0.3333333433	0.5352771878
398E5506-6D7B-4AEA-9875-9535B9084984	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	1094	166	414	85	243	86	NA	54	30	695.5109217201	0.1800000072	0.523627758
92330079-514D-4125-83F9-1E41F6064DE3	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	1138	169	414	86	242	86	NA	53	30	680.9173492912	0.1764705926	0.5143088698
CEE17EE8-D43B-4463-B631-7E1906073B22	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	1111	169	414	85	241	88	NA	55	31	671.2248972939	0.2199999988	0.5238150954
2DE65F83-5665-4C54-84F8-E38642ABCB11	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	900	NA	NA	NA	NA	1.5	N	922	163	376	78	211	87	NA	51	32	616.2550505932	0.2653061152	0.4687297046
D5F743C3-B431-46F2-9E0C-48A204EF782C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	900	NA	NA	NA	NA	1.5	N	1074	167	390	80	220	90	NA	53	33	635.5528732607	0.2115384638	0.4711805284
F021D25C-E815-4396-91AD-21C00835C59A	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	900	NA	NA	NA	NA	1.5	N	1075	165	386	80	217	89	NA	55	30	630.3416943297	0.1698113233	0.4681928456
43570F56-D20D-41BE-AFCA-34E1C257E5A1	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	1070	NA	NA	NA	NA	2	N	1044	166	377	80	210	87	NA	49	28	712.516632687	0.1632653028	0.4379416704
E0B1C62E-883E-47FE-966C-806F17C1DECD	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	1070	NA	NA	NA	NA	2	N	1112	169	382	81	217	84	NA	51	29	704.2746920911	0.200000003	0.4632142484
EA70AB8C-2368-416D-AB58-E4B20217B2F8	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	1070	NA	NA	NA	NA	2	N	1058	168	379	80	214	85	NA	48	31	693.1060263137	0.1800000072	0.4555298686
379B0E6B-A7F7-4F49-99E3-CAE72D7C6B56	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	1000	NA	NA	NA	NA	2.5	N	1116	169	390	79	225	86	NA	49	29	715.9907033603	0.1568627506	0.4833812118
49525B6B-A8F3-41F3-B39F-83F9BD79CC4F	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	1000	NA	NA	NA	NA	2.5	N	1029	163	385	78	221	86	NA	50	29	704.3870995804	0.2291666716	0.4785404205
898498F2-CF36-4102-BDF1-BEB569EA831A	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	1000	NA	NA	NA	NA	2.5	N	1072	162	388	79	225	84	NA	51	30	677.808225132	0.2199999988	0.4755049944
39D4BA66-5074-484F-93CA-6589186EBF4E	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	814	NA	NA	NA	NA	3	N	1049	161	381	79	219	83	NA	47	27	779.7181519919	0.1632653028	0.4538539648
86141953-3FD4-417F-B609-61DC8F5DCB34	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	814	NA	NA	NA	NA	3	N	1045	160	385	78	224	83	NA	46	29	762.6156877023	0.1599999964	0.4793850482
96BD9D67-E851-42B5-8983-2C426F2125A5	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	814	NA	NA	NA	NA	3	N	1069	166	385	79	226	80	NA	46	28	766.4455396739	0.1875	0.4711319506
3B185BE1-AA9D-4067-9F3B-812C1E238762	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	447	1450	NA	NA	NA	NA	6.5	N	962	159	374	76	207	91	NA	55	36	639.5832774439	0.1960784346	0.4638957679
5A05C8F1-B8E6-407B-AB27-CE72C53DEF35	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	447	1450	NA	NA	NA	NA	6.5	N	952	157	370	77	203	90	NA	55	38	645.1415356285	0.200000003	0.4559143782
6F486127-3DB1-46CC-9D98-ED557429D010	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	447	1450	NA	NA	NA	NA	6.5	N	890	159	370	76	205	89	NA	55	34	631.788127947	0.2244897932	0.4598039389
4CD4B566-D3E6-428A-82F8-DC92D3AE27F5	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	630	2160	NA	NA	NA	NA	7	N	1005	157	379	77	209	93	NA	56	36	667.5377019209	0.1764705926	0.4650630653
833C1B9F-6814-44F5-A659-DA7D24CCA20E	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	630	2160	NA	NA	NA	NA	7	N	916	159	367	76	199	92	NA	56	39	627.2735327567	0.1764705926	0.4568757415
9A3B8546-93BF-4B55-8A0F-321C1659CF57	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	630	2160	NA	NA	NA	NA	7	N	952	155	378	75	204	99	NA	55	41	574.3178647854	0.2599999905	0.4687643647
64D6D6D6-BAF9-403C-A83A-54EF08EB8219	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	659	1970	NA	NA	NA	NA	7.5	N	908	158	373	75	205	93	NA	49	40	616.5212962411	0.2156862766	0.4750114083
C7966E84-3192-4753-816E-320AEDF5070F	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	659	1970	NA	NA	NA	NA	7.5	N	960	156	377	76	205	96	NA	56	41	606.9716181068	0.2075471729	0.4833538234
E7F728C9-6AFF-40CD-95FB-2B99F2ACD8A6	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	659	1970	NA	NA	NA	NA	7.5	N	898	159	373	76	205	92	NA	54	45	614.5362461197	0.2199999988	0.4724853039
30A4442D-2668-49DE-A95F-343DD554A4A0	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	919	1480	NA	NA	NA	NA	8	N	1012	163	389	73	222	94	NA	61	37	666.1122605375	0.2181818187	0.4909256995
430F0595-DC6C-4D41-AB0F-8F97982D8CB1	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	919	1480	NA	NA	NA	NA	8	N	977	162	390	75	222	93	NA	64	39	652.8376744202	0.2641509473	0.4946397543
74B58E1E-B1F5-4907-946F-7EEEBA26ABB6	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	919	1480	NA	NA	NA	NA	8	N	976	163	389	73	223	93	NA	62	40	648.5134371611	0.2592592537	0.4999325275
4FB291FF-6A45-4148-A18F-54671F665971	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	2190	1850	NA	NA	NA	NA	12	N	968	161	408	75	223	110	NA	76	53	547.9670765882	0.629629612	0.5548155308
BE13634E-CFDC-4385-8E64-0BA4D3DF63E4	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	2190	1850	NA	NA	NA	NA	12	N	944	164	405	74	224	107	NA	74	54	563.2995037817	0.537037015	0.538598299
ECA1A484-E39B-4D24-AD1A-3C435877C7BA	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	2190	1850	NA	NA	NA	NA	12	N	985	164	406	74	225	107	NA	79	50	563.4227123562	0.5961538553	0.5517032146
43B20DEF-0A1B-4E1E-9965-70543D0F7F74	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	2110	2130	NA	NA	NA	NA	12.5	N	975	162	402	75	213	114	NA	66	60	552.6002380133	0.4181818068	0.5380590558
4D0CD717-F4B4-4BE9-9FD3-20A77EE1735B	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	2110	2130	NA	NA	NA	NA	12.5	N	907	162	397	75	207	115	NA	58	52	533.6565788226	0.6470588446	0.5208232999
AE006D9E-94D2-4190-BD89-ACFB7273963C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	2110	2130	NA	NA	NA	NA	12.5	N	958	162	397	76	209	112	NA	66	56	551.0769211701	0.400000006	0.5268822312
11D35C8C-9FD9-4F11-A8E5-54D2D3583B43	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	2110	2090	NA	NA	NA	NA	13	N	923	159	398	75	208	115	NA	66	61	524.8528160146	0.5576922894	0.5303644538
C269ED96-6A73-4CBD-BD9C-1361F2F34FDC	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	2110	2090	NA	NA	NA	NA	13	N	925	161	397	74	213	110	NA	60	52	530.3044432776	0.5094339848	0.5345568657
D88BA954-12FE-44F9-B1C8-F1F67EDFDF29	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	2110	2090	NA	NA	NA	NA	13	N	936	161	396	74	211	111	NA	69	57	534.7221093829	0.538461566	0.5320903659
5037070A-01DF-46F2-9706-631BD27B9DE3	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	1930	1650	NA	NA	NA	NA	13.5	N	966	160	404	73	227	104	NA	80	41	596.621996524	0.4814814925	0.5318546891
78A8F18A-82C0-420E-9A0E-246E7B48037A	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	1930	1650	NA	NA	NA	NA	13.5	N	971	160	406	73	233	100	NA	78	41	597.2420367417	0.5882353187	0.5400696993
EA1B8E17-A9D2-42F3-A9FF-787337B1ECB4	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	1930	1650	NA	NA	NA	NA	13.5	N	1012	165	407	70	235	102	NA	77	48	589.1457134729	0.519230783	0.5377105474
2F84E668-D0DB-476C-B706-9796034334DA	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	1068	168	408	87	230	91	NA	55	31	667.6582882166	0.269230783	0.5058072209
99E8FB2D-5B81-49AC-8A02-B988211AC80C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	1033	146	416	82	238	96	NA	60	34	624.3316479716	0.2857142985	0.5272801518
E93EE344-E2C7-4BBF-B333-70D10C032B2D	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-3-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	1072	152	412	86	235	91	NA	56	33	653.7129505687	0.3090909123	0.5175956488
4890740D-FE99-485A-992B-74364E646064	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	NA	NA	NA	-0.5	Y	1110	162	417	76	250	91	NA	62	35	639.311233242	0.1698113233	0.5188785791
781F263F-DCEA-4452-AF5F-C4400A1020EE	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	NA	NA	NA	-0.5	Y	1105	164	419	75	251	93	NA	60	35	620.8348987079	0.1509433985	0.5274561644
D563595F-6F32-4BB4-9BC3-A07A3F60C490	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	NA	NA	NA	-0.5	Y	1100	164	415	76	249	90	NA	62	35	640.1003899731	0.1851851791	0.5124615431
5B7FD75F-6224-4C14-8A4A-57D9EB90932C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	3360	208	NA	1.5	N	974	163	396	73	230	93	NA	69	38	564.0220446649	0.2727272809	0.5019475818
D5D3F2F9-182A-4DE4-AF46-83F924ED163F	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	3360	208	NA	1.5	N	989	164	398	70	238	90	NA	70	37	578.4389388298	0.3207547069	0.5085486174
FDE93902-C0D0-48FD-8BE9-816C5D60FADD	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	3360	208	NA	1.5	N	976	162	396	73	232	91	NA	69	39	563.2382663598	0.2321428508	0.5044977069
4FC2DD55-4361-4D5B-8ED3-782FCEF16DB5	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	4960	523	NA	2	N	913	148	393	69	231	93	NA	72	38	561.4951683333	0.2962962985	0.4934787452
C63A6E83-E07F-4C79-AA41-149E8042D91E	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	4960	523	NA	2	N	918	154	392	67	234	91	NA	71	37	566.5867602777	0.2884615362	0.4975182414
C8990C9D-B302-4BA7-8DDD-E27BB3CFEDF2	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	4960	523	NA	2	N	938	154	391	69	232	90	NA	69	37	582.0343960915	0.2678571343	0.5002655983
4DA4529E-4CF2-40F7-8992-2B464D9DAE76	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	4050	715	NA	2.5	N	950	149	393	70	230	93	NA	67	37	567.6701296998	0.2962962985	0.4945983887
7F24B510-9C5E-4848-9897-74145043E052	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	4050	715	NA	2.5	N	951	159	391	70	231	90	NA	63	37	592.3958410945	0.2363636345	0.4818996787
EC4F786C-3D52-4291-A180-4F9F65B84A14	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	4050	715	NA	2.5	N	990	161	399	70	234	95	NA	67	36	572.6543197613	0.2363636345	0.5107373595
155292EC-B922-4F2A-A062-3B3C2631A3CE	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	3820	716	NA	3	N	1018	160	398	73	233	92	NA	58	37	626.0982626974	0.1851851791	0.5137252212
6CED3AF0-8395-4710-9358-C7A43E6431E2	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	3820	716	NA	3	N	1029	162	395	71	235	89	NA	58	38	631.0974304202	0.1886792481	0.5120312572
C3DE4A41-5036-4625-BAAE-F8CBC2046BD3	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	3820	716	NA	3	N	1027	162	397	71	237	89	NA	61	35	635.4093992313	0.1481481493	0.5138025284
1F64CF10-F01F-4FE2-B894-B088F53EE802	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6820	915	NA	6.5	N	941	161	404	72	224	108	NA	67	45	513.6003681936	0.2068965584	0.5129628181
472A59E6-0E93-4B99-8AFC-6306B839E259	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6820	915	NA	6.5	N	914	155	404	73	227	104	NA	64	43	532.1085275307	0.2321428508	0.5031293035
F8193ECE-38C0-43C6-90BE-29B5A125D9B6	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6820	915	NA	6.5	N	897	152	397	68	230	99	NA	70	43	525.3995798593	0.2456140369	0.5005602837
07554931-AECF-4026-A051-76F288DABDB5	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	7950	1260	NA	7	N	863	159	405	70	230	105	NA	72	44	506.4889131425	0.3703703582	0.5135917068
96607D61-89B8-4B0D-85FD-66DABF252E0B	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	7950	1260	NA	7	N	844	159	399	69	228	102	NA	74	40	510.6761010954	0.3636363745	0.5034765601
F9301603-762E-44A8-96D4-D139FDED2352	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	7950	1260	NA	7	N	860	160	406	71	231	104	NA	74	46	496.9635142153	0.3454545438	0.5110087395
3B572E5F-7733-48EC-A31F-46651DFBB72C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6330	1440	NA	7.5	N	972	162	418	69	248	101	NA	71	43	524.1560946391	0.3272727132	0.5369175076
4C1B8CA9-2C7E-41BC-BE7E-FA2EB386FCEF	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6330	1440	NA	7.5	N	1012	162	411	70	240	101	NA	69	44	553.0966655364	0.2857142985	0.5265833735
D6356AEA-1041-45A7-9A2E-EBAC0346D7B6	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6330	1440	NA	7.5	N	967	161	420	70	246	104	NA	75	43	517.0468203846	0.3448275924	0.5421097279
A135E9EE-CF77-4CFE-9721-13CAE37CE878	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6590	1390	NA	8	N	888	156	397	71	226	100	NA	64	44	538.5563888287	0.2280701697	0.5012101531
B08F535A-F45E-4D44-A1A8-5417C8C030AC	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6590	1390	NA	8	N	955	157	406	73	231	102	NA	62	44	558.8336215742	0.2241379321	0.5113189816
C36BE2E0-E056-4A1E-B47A-CCD3D92A302A	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6590	1390	NA	8	N	959	161	402	72	230	100	NA	64	41	580.7979055836	0.2363636345	0.5043450594
1E581C60-53FA-4134-A1C7-4CF9A9CDC413	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	5500	863	54.8	12	N	949	168	409	73	223	113	NA	67	50	504.8758562567	0.3333333433	0.5360300541
69F0AB4F-58F9-4DB3-A9D4-497684B39BDF	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	5500	863	54.8	12	N	956	169	409	73	229	107	NA	67	44	540.3666421244	0.2857142985	0.5330983996
BBE88F5A-CE01-48F7-A5E7-3085B04D3567	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	5500	863	54.8	12	N	932	168	407	73	226	108	NA	68	45	533.3556615604	0.2909090817	0.5284702182
44385707-9A1B-4029-A8A6-084B960FDA84	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6240	1180	83.6	12.5	N	872	175	394	70	216	108	NA	68	50	511.5046455844	0.3157894611	0.5100628734
4A95AC22-FAA7-4780-996C-8FC9A8E16B46	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6240	1180	83.6	12.5	N	879	178	402	71	221	110	NA	73	45	500.1263114844	0.3389830589	0.5195542574
5C302FFB-5063-4FE2-A2BB-08D24EB52E43	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6240	1180	83.6	12.5	N	911	177	403	72	222	109	NA	67	47	530.6100409683	0.3103448153	0.5101313591
0422B7EE-F533-4868-8927-D0B69201DD6C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6050	1270	84.5	13	N	872	177	408	72	221	115	NA	72	49	485.3701897471	0.3454545438	0.5157992244
5392B8BF-2939-41B4-B6ED-65E234140545	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6050	1270	84.5	13	N	939	177	411	70	227	114	NA	71	48	502.9002097771	0.3103448153	0.5268825889
862F322E-0205-463C-8B07-ECF018E169B5	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6050	1270	84.5	13	N	936	175	411	71	228	112	NA	72	49	507.7646424961	0.2931034565	0.51930058
21EA0D9D-E224-4AD9-BEA6-A0956022E6EF	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	5540	1280	69.1	13.5	N	810	169	398	72	219	107	NA	63	48	553.0614561705	0.2295081913	0.5159279108
749E4C75-FB70-48B9-B1CF-9E34C064D3BB	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	5540	1280	69.1	13.5	N	911	169	400	71	219	110	NA	64	45	544.0273366977	0.1929824501	0.5001513362
F228830D-1783-49C0-B938-0ED257F2046C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	5540	1280	69.1	13.5	N	861	172	400	70	223	107	NA	66	45	525.9938967555	0.314814806	0.5144155025
32ECCD1A-D0D9-4D14-9B81-6E7C1D0E1C7E	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	NA	NA	NA	24	N	1127	166	447	70	257	120	NA	68	44	500.1396676121	0.3898304999	0.5626063347
75E66C49-AD0A-4419-93B0-26C20B9A7009	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	NA	NA	NA	24	N	1095	166	448	73	260	115	NA	67	45	512.9341378342	0.360655725	0.5695276856
A860A625-23B6-4D06-AB2F-6DE355FF8F5E	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-4-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	NA	NA	NA	24	N	1138	165	447	72	261	114	NA	69	42	520.2424658466	0.3442623019	0.5632929206
427E93C0-E6FA-4A94-88A5-1D89E34ACBDB	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	1135	153	412	68	256	88	NA	52	33	613.6289241997	0.2363636345	0.5305536389
858707C0-5A9E-4749-9977-85AC362C8EA4	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	1092	154	410	68	254	88	NA	52	33	624.0005322255	0.2222222239	0.5193823576
9522D42A-25B6-4F6C-BF5D-7C913F8656AA	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	1071	144	413	69	257	87	NA	55	32	619.2785147412	0.2181818187	0.5360149741
560AC590-53E8-4C45-8687-018E7724530C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	624	NA	NA	NA	1.5	N	952	165	365	73	209	83	NA	59	32	657.061607672	0.2083333284	0.4393973947
8869425B-E1DE-42CE-93F2-8654C9ACED9F	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	624	NA	NA	NA	1.5	N	904	165	363	73	207	83	NA	56	30	667.0433145859	0.1632653028	0.4574406445
8C97F731-413E-4448-BD04-2FAE34805636	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	624	NA	NA	NA	1.5	N	913	164	363	74	208	81	NA	58	30	677.6433302554	0.1568627506	0.4363828599
0C0ADDE0-A8FB-4A2C-A9C8-0F9A12CB7643	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	715	NA	NA	NA	2	N	972	163	364	69	211	84	NA	61	32	702.1815545642	0.1599999964	0.4336230159
C2FF3196-AD9E-464A-82A4-75164E5C6640	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	715	NA	NA	NA	2	N	1049	169	370	70	215	85	NA	62	34	687.4475673212	0.2083333284	0.4510007799
FCF9FC8E-B4E9-4954-9136-30BC637FC7C2	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	715	NA	NA	NA	2	N	895	166	357	68	206	83	NA	60	29	696.2985198967	0.1428571492	0.4282984436
2E086B59-7F7A-42FA-AF11-80EE5C37557C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	724	NA	NA	NA	2.5	N	1004	163	375	71	216	88	NA	64	34	644.9212698005	0.2244897932	0.4579455256
5089DBA5-7D5A-4471-A6F4-8A3C8BB7A06B	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	724	NA	NA	NA	2.5	N	991	164	374	69	217	88	NA	62	35	642.4781705891	0.200000003	0.4583716691
53181139-DE87-411E-86E1-11921F8661F0	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	724	NA	NA	NA	2.5	N	1044	167	378	70	220	88	NA	63	35	658.5672289898	0.1666666716	0.4520494044
157B98F4-0317-4835-9269-7FFA67302861	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	677	NA	NA	NA	3	N	1034	166	367	71	214	82	NA	55	30	757.872736571	0.1599999964	0.4274139702
3558FAED-CE59-4206-A111-B12656DD269A	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	677	NA	NA	NA	3	N	989	160	371	73	214	84	NA	57	30	728.9008564061	0.1568627506	0.447265029
84D488D0-CCFC-4A8D-ACB4-13024087DBF4	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	677	NA	NA	NA	3	N	1014	162	371	74	214	83	NA	54	31	734.5906547696	0.1599999964	0.4440048635
33D0C4F2-9DC9-47D2-B8E2-3C79E269C3C7	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1380	NA	858	NA	NA	NA	6.5	N	978	162	390	72	216	102	NA	63	46	569.2888903941	0.2727272809	0.5093219876
84DC8EED-7EA8-4600-83BE-D7D50183808B	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1380	NA	858	NA	NA	NA	6.5	N	980	161	387	72	217	98	NA	62	43	577.3778667508	0.2413793057	0.5136354566
C5C15F06-00B4-4A75-A156-F8F5825A9A21	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1380	NA	858	NA	NA	NA	6.5	N	900	160	386	72	216	98	NA	62	46	558.1354739807	0.3518518507	0.5182875991
CE9EB2EC-320C-4222-9874-DBDC2D7B659E	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1370	NA	951	NA	NA	NA	7	N	1009	163	395	71	215	109	NA	71	55	534.4520759763	0.3275862038	0.5286039114
D825C804-E24C-451E-851A-B90F68D4CFBD	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1370	NA	951	NA	NA	NA	7	N	947	165	397	72	215	110	NA	69	55	513.7660798395	0.4210526347	0.5243612528
DF408631-D520-4A6B-80B6-A99C61DC12C5	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1370	NA	951	NA	NA	NA	7	N	949	162	391	71	216	104	NA	71	49	547.6975708379	0.3859649003	0.5178886652
0381E29B-6A86-4999-94F1-BF024AFA5FC9	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1280	NA	953	NA	NA	NA	7.5	N	954	160	392	69	224	99	NA	71	42	580.7934284919	0.4181818068	0.511803329
319E54DE-CB6C-4F19-99FE-F839E074826A	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1280	NA	953	NA	NA	NA	7.5	N	990	164	396	71	226	99	NA	70	47	592.6112082835	0.3962264061	0.5217431188
C2FDC3B7-E285-4CDD-ABB8-C70E873B32DA	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1280	NA	953	NA	NA	NA	7.5	N	986	161	394	70	228	96	NA	75	40	608.9454957931	0.3818181753	0.5140162706
32CB5FB4-863C-4BCF-BB91-35060D473186	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1250	NA	930	NA	NA	NA	8	N	926	161	383	72	215	96	NA	63	38	624.3528501718	0.2592592537	0.4887167811
CCDB0741-F421-44B8-860B-C4D1124B3207	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1250	NA	930	NA	NA	NA	8	N	911	159	386	73	219	94	NA	63	35	634.4829756638	0.2592592537	0.485586673
E608F09F-720D-464B-9246-806199CA914C	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1250	NA	930	NA	NA	NA	8	N	972	159	385	73	221	91	NA	60	32	698.0688767568	0.1666666716	0.4758661389
2DB2CBE7-B6F2-419E-AD79-4BEEBEBE2057	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1960	NA	1430	NA	NA	NA	12	N	904	160	382	72	205	105	NA	63	39	634.585047622	0.137931034	0.4792592525
56D6B1C3-93C9-46F7-A5EE-A0AC4B1420F9	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1960	NA	1430	NA	NA	NA	12	N	841	160	379	72	201	106	NA	55	52	600.6257400282	0.2830188572	0.4845821559
C1584A55-35EE-4D95-8E0A-A1BC64C1229F	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1960	NA	1430	NA	NA	NA	12	N	852	159	378	72	199	107	NA	60	49	612.438637209	0.1694915295	0.4836847484
0319214B-1559-4B14-8252-6659E91A480D	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1940	NA	1520	NA	NA	NA	12.5	N	939	162	390	69	216	105	NA	65	47	644.3833127712	0.3333333433	0.5127341747
2BB2026F-62FE-4D8C-80EF-1F1C0CB9B3F2	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1940	NA	1520	NA	NA	NA	12.5	N	849	161	380	71	205	104	NA	68	45	629.3487045553	0.2678571343	0.4934401214
5EE14334-DC40-4FB1-99EB-01755D033D96	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1940	NA	1520	NA	NA	NA	12.5	N	852	161	388	72	210	106	NA	67	45	625.1050430181	0.3272727132	0.4962767363
23AC224F-3F54-4174-A484-429CFA7CE8E5	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1990	NA	1550	NA	NA	NA	13	N	944	162	391	72	209	110	NA	60	53	616.5077684103	0.2280701697	0.5064709187
7FB3D3C2-9C9A-4447-8F2D-FC45A56D50E4	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1990	NA	1550	NA	NA	NA	13	N	944	157	397	73	210	114	NA	57	56	606.5199537027	0.1833333373	0.5153920054
86DDC8F8-3998-49AF-A88C-6FD1769A94D6	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1990	NA	1550	NA	NA	NA	13	N	943	158	394	73	210	111	NA	59	53	629.9813650943	0.2203389853	0.5134862065
A58283A9-8D31-42E8-9EFF-D73FCB540AD6	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1960	NA	1570	NA	NA	NA	13.5	N	895	158	386	72	204	110	NA	64	51	597.1485341579	0.2678571343	0.4940763116
B1B913CE-E3F8-411F-B646-54C84C2E9778	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1960	NA	1570	NA	NA	NA	13.5	N	872	159	388	72	205	111	NA	60	53	596.8090894379	0.2807017565	0.4994857609
BA2CA502-D346-4380-B515-ABBA32578EF4	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	1960	NA	1570	NA	NA	NA	13.5	N	923	158	388	72	206	110	NA	61	51	619.9157406261	0.2142857164	0.4998833537
121B4FA8-E52C-4F88-B520-505D8FB987ED	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	1042	164	397	68	238	91	NA	68	36	714.8964384227	0.2830188572	0.5044236183
22780E0E-4D34-491D-A76B-7EA1471C600D	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	1047	165	398	68	239	91	NA	70	37	688.1258197959	0.3333333433	0.4991211295
DE6CA1B3-3279-4CA7-8BD6-F897BB5D3F87	2001	M	21	175	60.3	125	69.33	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	E-A-B-D-C	PERIOD-5-DOSING	Mexiletine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	1068	164	399	69	240	90	NA	67	36	722.7663311603	0.2592592537	0.4979297817
10EB996F-03F7-4E13-BD49-EB03700A360B	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	896	172	382	89	220	73	NA	43	27	716.818925914	0.1395348907	0.3402266204
350779C1-3425-4339-865D-508E6C328C1D	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	847	171	379	89	218	72	NA	48	28	691.712267015	0.1395348907	0.3520620465
AFA2F720-8457-4D58-B778-381708E45C23	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	830	171	375	89	214	72	NA	43	26	683.0285779522	0.1707317084	0.3399906754
00B0AC34-2410-4659-8356-DBBB8F554BF1	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	532	NA	NA	NA	1.5	N	787	165	346	86	186	74	NA	47	29	622.3550555196	0.1162790731	0.3060350418
98B0BDF5-D22B-43FB-AD1E-E41FAAFD7433	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	532	NA	NA	NA	1.5	N	758	167	345	88	184	73	NA	44	27	608.6888313376	0.1395348907	0.3000395596
C2F6E560-0046-4C81-AC9B-054BB6564BCE	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	532	NA	NA	NA	1.5	N	790	167	346	86	187	73	NA	48	28	622.8941460205	0.095238097	0.2929250598
11EE6587-27D5-4E1C-BC2C-5F6E45244A73	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	616	NA	NA	NA	2	N	751	161	346	88	188	70	NA	43	25	632.3608779804	0.1395348907	0.2946071625
41294309-CA9B-4A7D-BA92-BAE6F56D773A	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	616	NA	NA	NA	2	N	724	176	340	86	182	72	NA	44	26	632.7158529072	0.1395348907	0.2980771065
97A10C5B-2BAD-460D-925E-1E178F52A8FE	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	616	NA	NA	NA	2	N	802	164	348	86	190	72	NA	47	27	651.9603493882	0.1395348907	0.2988874316
7841F1D3-F947-4DE9-A83D-53EE93CA9A8E	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	691	NA	NA	NA	2.5	N	737	167	341	86	182	73	NA	43	27	626.369821409	0.1395348907	0.29323861
81621D52-9EEB-46B3-B3AD-FCE458A29C0A	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	691	NA	NA	NA	2.5	N	758	166	343	86	185	72	NA	41	25	643.8152237947	0.1162790731	0.2783053219
FA1C6040-1803-4093-8CAC-6061EE3F8CB8	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	691	NA	NA	NA	2.5	N	777	164	342	86	184	72	NA	46	27	659.2100747337	0.1162790731	0.2838477194
72DE2C1E-7FD0-4276-93F5-E3732FAB342A	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	711	NA	NA	NA	3	N	720	169	335	84	176	75	NA	41	27	606.5666886435	0.1086956486	0.2841573358
7EDD412B-3638-4643-8489-28B02A34D485	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	711	NA	NA	NA	3	N	729	169	334	84	174	76	NA	40	26	626.1979439897	0.1086956486	0.2817217112
A52A6251-4000-48F3-B06A-223149C29161	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	711	NA	NA	NA	3	N	722	169	336	85	175	76	NA	40	27	613.4707247038	0.1304347813	0.2845575213
2DF1A770-307D-4666-AA54-B245B82F30E6	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1450	NA	1510	NA	NA	NA	6.5	N	696	162	354	89	182	83	NA	56	36	454.6641557056	0.1632653028	0.3538995087
78978C61-5441-451C-9745-652DF1C76C2E	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1450	NA	1510	NA	NA	NA	6.5	N	705	165	356	90	182	84	NA	58	35	466.652446907	0.1599999964	0.3525213003
C3AE93AC-128B-44F5-8C02-466CD3E999AC	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1450	NA	1510	NA	NA	NA	6.5	N	730	158	355	89	183	83	NA	58	33	468.956042434	0.1304347813	0.3592932224
626BC14E-D67D-4710-BEC4-E51E85B92DE8	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1370	NA	1520	NA	NA	NA	7	N	786	162	358	89	189	80	NA	59	35	445.4851797248	0.227272734	0.3611141443
BF2DB379-6A22-4243-BF84-487E94253A03	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1370	NA	1520	NA	NA	NA	7	N	784	161	359	89	186	84	NA	61	37	461.7332775501	0.1666666716	0.3795621395
FEA7513C-186B-4B19-8A47-6F897D47DCB0	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1370	NA	1520	NA	NA	NA	7	N	731	163	356	89	183	84	NA	61	34	453.5239892794	0.1777777821	0.3455033302
7F3C87DE-582D-427F-ACB3-047CF14C8DA6	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1340	NA	1530	NA	NA	NA	7.5	N	655	167	350	91	170	89	NA	56	42	401.6008081426	0.0961538479	0.3610590994
C20554AB-3A1F-4229-B08C-FA6E4A1726A4	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1340	NA	1530	NA	NA	NA	7.5	N	690	165	350	90	176	84	NA	54	39	434.4088688488	0.1739130467	0.3484703004
E66CAFD2-A89C-435A-9D25-3BDC5D8B7871	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1340	NA	1530	NA	NA	NA	7.5	N	711	159	349	89	180	80	NA	59	34	439.2281022313	0.1702127606	0.3526514471
AB286607-1235-4E3E-9E13-2CD35A7ABF0E	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1160	NA	1360	NA	NA	NA	8	N	720	168	355	89	181	85	NA	51	34	513.117988737	0.1224489808	0.3393943608
D44D8AD0-B95A-42AC-9988-401CF5E751B9	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1160	NA	1360	NA	NA	NA	8	N	730	167	357	89	183	85	NA	55	32	502.3398980625	0.1836734712	0.355607301
F7167334-C305-470C-A1B8-5E25F7A2F13E	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1160	NA	1360	NA	NA	NA	8	N	688	163	350	86	182	82	NA	54	31	516.4609324534	0.1666666716	0.3402992785
5B2A5782-95E7-478C-9B32-50E35A81AE62	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	2160	NA	1890	NA	NA	NA	12	N	731	173	369	91	189	89	NA	57	45	434.4713707324	0.1800000072	0.3967326283
5CC7C71E-38D0-4FB9-B036-AAB8DB102573	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	2160	NA	1890	NA	NA	NA	12	N	751	173	370	91	192	87	NA	61	41	426.3745115131	0.2399999946	0.4138057828
A30EE326-A96E-4249-90EC-369B728D83A3	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	2160	NA	1890	NA	NA	NA	12	N	753	175	368	91	190	87	NA	63	40	409.6745873368	0.2127659619	0.410728395
0DCEA585-5C09-42FC-9FEC-E16E0C4C08A1	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1990	NA	1960	NA	NA	NA	12.5	N	720	174	364	90	184	90	NA	59	45	397.8006091003	0.2199999988	0.3985591829
605E3F4F-C9F7-4ED2-BC84-6699FA3E79E9	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1990	NA	1960	NA	NA	NA	12.5	N	697	173	365	92	182	91	NA	59	48	384.2833692466	0.1836734712	0.3923817575
68E3ECF7-107F-478D-8813-FA4767966194	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1990	NA	1960	NA	NA	NA	12.5	N	753	171	366	91	183	92	NA	61	40	413.6456083653	0.1346153915	0.3804163039
7DE73757-6429-498A-8006-D0B2580DC501	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	2000	NA	1830	NA	NA	NA	13	N	753	172	365	90	187	88	NA	59	37	431.813668224	0.2173912972	0.37682423
8E4EF60A-4AF2-446B-8CE4-3F4D91FB498C	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	2000	NA	1830	NA	NA	NA	13	N	756	169	362	88	187	87	NA	62	37	426.2132769197	0.2173912972	0.3880010545
F4E48CAB-31D9-4290-A070-607AA108BE60	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	2000	NA	1830	NA	NA	NA	13	N	750	174	358	90	185	83	NA	62	34	441.3650327835	0.1739130467	0.3735384345
01E3F10D-69D1-4C63-9577-48E1A64F2A24	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1740	NA	1880	NA	NA	NA	13.5	N	738	174	362	89	186	87	NA	62	36	429.4294484327	0.1632653028	0.3783617616
05E73548-37FE-4B46-9DC8-C65700FA6272	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1740	NA	1880	NA	NA	NA	13.5	N	707	179	365	91	188	86	NA	64	34	430.8402008428	0.1800000072	0.3883005977
22DFE8B7-84AE-4C89-9D3F-7F01DE802EF6	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	1740	NA	1880	NA	NA	NA	13.5	N	775	175	367	90	191	86	NA	62	35	451.154747336	0.195652172	0.3810958862
BC2D60FF-E7EC-46D2-8093-69FD75EF732B	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	785	173	358	87	193	78	NA	48	30	575.248362835	0.1521739066	0.339846015
CFD1677D-D5F6-48F1-801E-2F69ACB2910D	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	725	183	352	87	185	80	NA	49	32	549.1314687883	0.1666666716	0.3383905292
F53DE731-A6C4-4208-A79E-0A4BF4F991C5	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-1-DOSING	Mexiletine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	752	180	358	88	190	80	NA	51	30	570.6034892326	0.1818181872	0.3278843164
623CB2EC-980B-46B4-8C84-C8D32E0CAB21	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	922	180	375	88	214	73	NA	46	28	682.3590900866	0.1190476194	0.3440852761
79CEB05E-544C-4FE1-B9C1-74FE7561E269	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	797	182	357	86	201	70	NA	43	24	645.3570378934	0.1190476194	0.3237838745
EBCD96AC-F6CD-4D3D-9B16-DF5CD8B06CCE	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	839	176	365	88	206	71	NA	43	25	652.2688377265	0.146341458	0.3308590949
41011C53-9B56-4499-AAEE-F9FC41C3CEF6	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	981	NA	NA	NA	NA	1.5	N	778	176	346	89	185	72	NA	43	26	598.7035295272	0.1190476194	0.2897154391
9B8E33A7-7E7E-4C1D-B372-48B35E835B31	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	981	NA	NA	NA	NA	1.5	N	778	179	346	88	186	72	NA	47	28	618.0046767612	0.113636367	0.3057854176
DF303C8C-1968-4224-BE6E-32682F752685	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	981	NA	NA	NA	NA	1.5	N	773	177	343	87	186	70	NA	47	29	612.1269741552	0.1707317084	0.2747829556
22512917-FF7E-4F78-B583-7858072EC712	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	1210	NA	NA	NA	NA	2	N	764	172	342	88	181	73	NA	46	27	621.2792533459	0.1666666716	0.279183507
92AAA4EB-F713-41CA-AC87-E4A23F669597	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	1210	NA	NA	NA	NA	2	N	781	166	345	88	186	71	NA	48	26	623.7635317939	0.1162790731	0.2974129617
ED9D2584-3E6E-46CE-A329-D3760E9F8927	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	1210	NA	NA	NA	NA	2	N	763	165	342	86	186	70	NA	46	27	624.2270804617	0.1190476194	0.2942451239
4BE09DB1-AF77-48C8-9F90-D6BC5DCF75DB	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	1070	NA	NA	NA	NA	2.5	N	817	175	346	89	186	71	NA	41	24	664.4233540531	0.1190476194	0.2991820574
AF82A7B7-CBB4-4B44-B0E4-3649A51BB90E	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	1070	NA	NA	NA	NA	2.5	N	812	169	347	89	187	71	NA	45	27	649.6207364972	0.0930232555	0.2921867669
C9471C59-B2E5-44B6-8924-EF2FEAAB14FA	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	1070	NA	NA	NA	NA	2.5	N	765	177	346	88	186	72	NA	46	26	673.2696351639	0.1395348907	0.2929155827
4C61AC0C-0764-41AF-94B5-1783176546FE	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	814	NA	NA	NA	NA	3	N	801	165	357	87	197	73	NA	42	25	676.2365879323	0.1190476194	0.2928936183
D5131873-D313-4783-8311-EFF6F7021AB7	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	814	NA	NA	NA	NA	3	N	931	170	360	87	200	73	NA	40	25	734.2702208074	0.095238097	0.3041918874
DC23BCC4-6A94-4A94-B03D-158772006AEC	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	814	NA	NA	NA	NA	3	N	861	169	354	86	197	71	NA	44	27	705.6214953609	0.0930232555	0.2823995948
23E963BF-DC45-4F6F-8885-10775BA2F398	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1440	1850	NA	NA	NA	NA	6.5	N	746	172	361	89	191	81	NA	61	34	482.4389013615	0.1555555612	0.3669960797
4D23B80F-2351-4CB9-8D76-C754059499D7	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1440	1850	NA	NA	NA	NA	6.5	N	779	168	362	87	193	82	NA	56	34	518.9083246149	0.1224489808	0.3679787517
ABC87493-1FD1-4D09-A2D3-40C3AB9B5C76	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1440	1850	NA	NA	NA	NA	6.5	N	788	176	365	89	193	83	NA	53	31	500.8348674886	0.1777777821	0.371984154
6D8CF474-FE90-49BC-ADCD-101F1768889C	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1480	2070	NA	NA	NA	NA	7	N	707	171	365	89	184	92	NA	60	47	374.7646046772	0.1914893687	0.3901298046
90C5A112-F66F-4F63-8A4E-10CA1300C43C	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1480	2070	NA	NA	NA	NA	7	N	815	175	376	90	196	90	NA	64	38	421.8770626891	0.2391304374	0.4080676138
BC81E2CD-35F0-4832-97C5-2FF259F66220	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1480	2070	NA	NA	NA	NA	7	N	792	174	379	92	197	90	NA	57	43	431.4625852096	0.2244897932	0.4102015495
0EB444EE-D126-4552-824B-4E40FCA9E45F	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1450	2070	NA	NA	NA	NA	7.5	N	701	173	365	89	191	85	NA	62	36	410.9148965761	0.2127659619	0.401858747
30CCCF56-9E34-44C4-8AB8-CF41659006A9	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1450	2070	NA	NA	NA	NA	7.5	N	754	174	364	89	192	83	NA	56	34	469.68518225	0.1739130467	0.3795932829
3BB31587-E8D6-461A-8E62-1B35CBABBDFA	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1450	2070	NA	NA	NA	NA	7.5	N	767	168	367	90	195	82	NA	57	33	470.6186153485	0.1666666716	0.3993497491
30199E63-398E-450B-953B-6F04664F41BC	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1230	1450	NA	NA	NA	NA	8	N	771	177	368	89	198	81	NA	54	33	518.1194531985	0.1739130467	0.3778423071
6BDE6EF5-61D9-4CD1-A72D-D29D9B3ECF5A	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1230	1450	NA	NA	NA	NA	8	N	781	173	367	87	199	81	NA	52	31	536.2172259398	0.1333333403	0.3649846315
AC8089D0-F59F-4A93-BCF6-55EC48964679	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1230	1450	NA	NA	NA	NA	8	N	767	169	366	89	196	81	NA	53	29	528.4852734053	0.1590909064	0.3781349957
A67CD38C-D839-44DE-8BF2-D7519726B4A7	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	963	1980	NA	NA	NA	NA	12	N	759	174	361	89	191	81	NA	52	32	548.4619304355	0.1224489808	0.3531601429
AD2BA2DB-2A41-4630-897C-F7AA3F68DEC9	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	963	1980	NA	NA	NA	NA	12	N	787	172	366	91	195	80	NA	52	30	567.3916117118	0.1521739066	0.3383972347
E20A4E61-2C2B-4C61-91AE-2C08FB9F376F	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	963	1980	NA	NA	NA	NA	12	N	759	175	360	89	191	80	NA	54	31	542.03350257	0.1428571492	0.3644301891
549F9948-974C-4905-9E2F-3283EB9FF13D	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1060	2080	NA	NA	NA	NA	12.5	N	768	171	365	89	193	83	NA	54	31	510.1256992984	0.1428571492	0.3681442142
870F2907-6BB7-4BAB-A32C-02B721233054	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1060	2080	NA	NA	NA	NA	12.5	N	773	168	364	90	191	83	NA	56	31	494.0042407169	0.1276595742	0.3629550934
B452EFD2-72FB-4B3A-8480-9018FC4C03C2	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1060	2080	NA	NA	NA	NA	12.5	N	768	165	363	90	190	83	NA	57	31	501.5902807106	0.1632653028	0.3672406077
BAA6EBAA-636D-4672-A073-FFAB85865C90	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1210	2210	NA	NA	NA	NA	13	N	746	180	367	89	197	81	NA	56	31	495.6687530219	0.195652172	0.3815793693
BC338A7C-EEFD-4D4E-99A6-0A00438845E1	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1210	2210	NA	NA	NA	NA	13	N	823	175	369	90	196	83	NA	54	30	520.5498458568	0.1458333284	0.3643109202
EA5B7F04-4947-4781-9439-A5CE76F553BC	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1210	2210	NA	NA	NA	NA	13	N	767	176	367	90	195	82	NA	54	30	520.3597607025	0.1521739066	0.3716688156
079D1B82-FBB0-4848-97D5-2EFE8E902C30	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1190	1570	NA	NA	NA	NA	13.5	N	855	173	375	90	205	80	NA	62	34	568.5114263469	0.1458333284	0.3883698583
6C1ED8E6-7C4B-45FC-A8E2-EE3D92813A4B	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1190	1570	NA	NA	NA	NA	13.5	N	810	173	373	89	204	80	NA	55	32	569.5621563555	0.1739130467	0.3823352754
8FC2E273-6DFF-46E3-818F-30E5CC539D3A	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	1190	1570	NA	NA	NA	NA	13.5	N	824	172	373	88	202	83	NA	55	30	558.9084372327	0.1666666716	0.3878574371
64C6A48A-9F28-42D9-9C47-C689AA596EFB	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	754	165	369	88	203	78	NA	49	28	595.932562904	0.1702127606	0.3508393466
CAEFBF6D-5850-48FA-B558-1C37EA05E5DC	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	751	166	367	87	203	77	NA	49	28	610.4291113622	0.2325581461	0.3410395086
D05F58E1-BE70-49D8-B4B7-19C293095BFB	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-2-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	720	177	368	86	204	78	NA	50	29	586.8469266918	0.2222222239	0.3521781564
0783D5DF-865C-45FA-90B0-9667EA9BF939	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	NA	NA	NA	-0.5	Y	950	166	383	104	211	68	NA	43	27	585.182826217	0.097560972	0.3638006449
53733326-6DAC-45CD-AEE2-6E51BAC62F72	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	NA	NA	NA	-0.5	Y	920	168	378	103	208	67	NA	45	25	581.4374226775	0.1219512224	0.3702618778
6AAD6EDA-DE4B-4920-9A1C-65EC0022B88D	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	NA	NA	NA	-0.5	Y	927	163	384	103	213	68	NA	44	26	588.8784925994	0.095238097	0.3684172034
512EFAC8-12E3-4AEB-8E81-96758416BD40	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	4020	258	NA	1.5	N	687	176	338	88	181	69	NA	44	23	609.1306182126	0.146341458	0.29586941
5833C1DF-342C-4DAF-A3BB-9530279A7AC1	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	4020	258	NA	1.5	N	670	177	338	88	182	68	NA	42	24	604.1335972704	0.1190476194	0.2878098786
92A9BDBD-D660-40DF-851D-539688736E2E	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	4020	258	NA	1.5	N	687	179	339	85	186	68	NA	43	23	622.4055011728	0.146341458	0.3018795252
1270F246-C920-4E0F-966E-57C99771386B	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	7110	642	NA	2	N	710	176	348	87	190	71	NA	44	24	595.5693100506	0.195121944	0.3204996884
52A1FD2B-D6A7-450A-B77D-C405DACDC56F	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	7110	642	NA	2	N	764	173	351	89	190	72	NA	42	25	616.7728174044	0.1162790731	0.3344559371
DA36A798-9BC9-4F77-A2C3-EAF08BC201BE	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	7110	642	NA	2	N	698	177	343	88	186	69	NA	43	25	583.8948785402	0.1162790731	0.310289979
612D8C1C-A7EE-4777-B3A2-6A1D8AD27C96	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	7060	902	NA	2.5	N	816	176	363	88	201	74	NA	45	25	639.5777076472	0.1190476194	0.322268039
69F3351A-2368-463A-A83D-0A2D188089E8	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	7060	902	NA	2.5	N	764	174	361	88	202	71	NA	41	25	644.9096800889	0.1395348907	0.3074824214
E2EBED00-9026-432C-81A4-9D9A68FD979F	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	7060	902	NA	2.5	N	756	175	361	88	202	71	NA	44	25	622.8307245232	0.1666666716	0.311962992
00AC8579-8E89-4E86-99B1-35BA27FE05E5	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6090	921	NA	3	N	775	170	362	87	199	76	NA	44	25	614.9634319641	0.1428571492	0.332894206
11868B7E-444A-4712-95DB-A57EFB4C061D	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6090	921	NA	3	N	765	170	360	88	198	74	NA	45	25	593.9293624031	0.1666666716	0.3438452184
DDB9B7B5-1897-4899-917C-C8C86B321299	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	6090	921	NA	3	N	782	175	362	89	199	74	NA	45	25	606.6938830856	0.1627907008	0.3301798105
A3F60D41-8454-435F-8130-65205FE493A6	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	9330	1370	NA	6.5	N	727	168	360	89	195	76	NA	48	29	560.0525028231	0.1590909064	0.3547486663
CB43DBD0-3505-438B-BA11-63B83FB4D578	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	9330	1370	NA	6.5	N	751	165	362	89	197	76	NA	48	28	556.5384294952	0.1363636404	0.3714434803
EB6377CC-46DB-46FB-BD97-1FD1DBC82D12	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	9330	1370	NA	6.5	N	726	168	361	88	197	76	NA	47	28	565.9881404298	0.1162790731	0.3613414466
29907A43-C646-4430-88AA-BEB4FC3DF472	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	12300	1800	NA	7	N	755	171	365	90	199	76	NA	52	28	519.1296417995	0.1521739066	0.4015966356
BEAB729F-9009-4CC2-A0D1-1462B67A2BC9	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	12300	1800	NA	7	N	710	168	358	88	194	76	NA	55	28	499.8930267349	0.2093023211	0.4025833607
DFC23C49-5F59-4AB2-869C-E313BECCC716	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	12300	1800	NA	7	N	732	167	361	89	197	75	NA	53	29	468.6801482412	0.1590909064	0.4133648574
26148692-D180-481B-8BD3-4D01D46526CB	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	11600	2060	NA	7.5	N	722	173	362	88	197	77	NA	63	32	503.7566153435	0.1555555612	0.3984617889
A5549D2F-6D88-4E77-8056-E299C0CEF807	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	11600	2060	NA	7.5	N	715	175	365	90	196	79	NA	52	28	523.2295605956	0.125	0.3990753293
D453A884-76BF-46DE-B9F0-A4DB9F4733A4	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	11600	2060	NA	7.5	N	692	177	361	88	195	78	NA	51	30	518.2718325679	0.1489361674	0.3900809586
254AEA24-EFB6-4180-AF31-7E5D521FB298	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	10500	2120	NA	8	N	765	168	366	89	197	80	NA	52	30	549.8217344204	0.1458333284	0.3900877535
3E1D2C68-286A-491D-8EC6-0403E1228747	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	10500	2120	NA	8	N	761	173	369	87	200	82	NA	51	30	573.009712864	0.1458333284	0.3931233883
9F1DCEC6-8239-4EEB-B432-7B6ED4093C25	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	10500	2120	NA	8	N	688	174	367	88	197	82	NA	53	30	535.6874349318	0.1632653028	0.3952842355
5F243418-8CF8-428A-9164-627063783724	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	12900	1950	69.4	12	N	644	184	351	87	179	85	NA	50	31	518.5438426361	0.1224489808	0.3425525427
7F707612-B369-4682-92C7-5DB8C5058F48	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	12900	1950	69.4	12	N	663	185	352	88	183	81	NA	50	31	542.1689088976	0.125	0.3434924483
E7E8A577-331A-464C-891D-7DBEA632A521	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	12900	1950	69.4	12	N	634	184	353	88	180	85	NA	50	32	517.560618047	0.1458333284	0.3425186276
2512AF8F-51C0-45E5-AE49-1F858FE19D1F	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	10600	2160	86.9	12.5	N	721	189	365	87	194	84	NA	57	35	489.1713290631	0.1836734712	0.406573683
50A3D81F-881D-4EA8-B1AC-73CEC0BCB890	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	10600	2160	86.9	12.5	N	689	192	361	87	192	82	NA	54	32	517.6123070783	0.1599999964	0.3981091678
BBEDA737-C8FB-4E7D-B136-85C3897B5589	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	10600	2160	86.9	12.5	N	663	206	362	86	191	85	NA	62	32	498.1560402936	0.2340425551	0.3997763097
9B74FAF8-2CDB-43DF-BCEC-FB528A2973FB	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	10400	2160	84.2	13	N	638	198	362	87	189	86	NA	77	41	466.060879161	0.1923076957	0.4190524817
DA8F8ECF-B7C8-4C98-BF83-2208CDC03EF9	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	10400	2160	84.2	13	N	614	206	362	86	189	87	NA	87	42	421.7448186556	0.3000000119	0.4369740784
E10C7502-3B97-4FD8-945F-CF9E841D283E	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	10400	2160	84.2	13	N	702	189	363	89	190	84	NA	63	31	485.7957592028	0.1764705926	0.4087702632
02768974-6D23-46C7-B088-2F725FBE8562	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	9390	2100	57.9	13.5	N	766	179	372	88	198	86	NA	69	37	505.7684208744	0.1599999964	0.4254010916
741E48DE-020E-45E2-9F17-E62BAFE1E720	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	9390	2100	57.9	13.5	N	747	184	374	87	201	86	NA	58	33	521.1389136884	0.1875	0.412987113
D2968355-9204-41B7-A833-FB66C5937673	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	9390	2100	57.9	13.5	N	730	179	369	85	197	87	NA	64	39	536.1035617843	0.1458333284	0.4147166312
609342DC-34BE-4461-BA4D-97366F663871	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	NA	NA	NA	24	N	783	166	386	87	215	84	NA	54	30	574.9854423456	0.2391304374	0.4039463997
6AEA5A98-7C68-4A27-A374-C03F9DA53404	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	NA	NA	NA	24	N	826	169	383	86	214	83	NA	50	31	579.3607606579	0.1875	0.3975191712
7BC4BAF6-62AE-481A-92E0-3EBF2C24188D	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-3-DOSING	Moxifloxacin + Diltiazem	NA	NA	NA	NA	NA	NA	24	N	846	168	383	87	214	82	NA	52	30	587.5121592277	0.1875	0.3891629577
1322E132-78A1-4FD9-8B2D-C8CCF767CC61	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	-0.5	Y	780	182	364	89	203	72	NA	42	25	708.9255290401	0.113636367	0.3401714563
20C24FBB-B3B2-4402-A658-B39F23F9DF32	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	-0.5	Y	894	185	374	89	211	74	NA	43	25	695.223625478	0.1304347813	0.3509018719
DAA53825-2DD9-4FC7-9973-0E5B8BB6E482	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	-0.5	Y	905	186	374	90	210	74	NA	42	26	722.7266607806	0.1395348907	0.3515282869
1F3EBFF6-6387-4B9D-A94E-3FF20150B21A	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	1.5	N	737	181	341	89	181	71	NA	42	24	617.4755753118	0.1162790731	0.3061494529
69999E69-C7B1-40BC-A0A7-BAD4D67C8E64	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	1.5	N	790	176	348	90	188	70	NA	40	23	670.5884989321	0.1428571492	0.291085273
79D4B4B8-1B97-4A88-B9AC-DC55B46E430B	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	1.5	N	798	174	344	89	184	71	NA	41	25	650.918966684	0.095238097	0.2813258171
04E53AB7-F59B-4618-969F-13EF151A282F	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2	N	779	180	343	87	185	71	NA	45	27	658.366251998	0.1219512224	0.2951185405
731A2745-9FAF-4CAD-A4ED-DA20DDF00C6B	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2	N	963	178	360	86	201	73	NA	45	28	727.9943869561	0.0909090936	0.3338925838
7DC71068-75F7-4384-B2C9-CC5808BBEED7	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2	N	677	181	343	87	186	70	NA	42	23	596.1230456673	0.174999997	0.3146229386
D17EC37A-4683-40D8-84F4-4E4D2C783817	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2.5	N	820	180	342	86	186	70	NA	45	26	665.1546332557	0.125	0.2864804268
E053BEE1-1EA0-4AA2-89E9-5105D928D7B9	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2.5	N	813	180	346	87	187	72	NA	38	25	704.556956522	0.1190476194	0.2891078889
FF7ABEAA-AD3A-4B7D-95DF-04052B5631BC	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2.5	N	797	178	346	88	187	71	NA	42	26	708.8586968489	0.095238097	0.3004329503
86229339-767E-4DD4-9871-124D4D9FB71E	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	3	N	781	179	350	89	187	74	NA	46	29	658.1979338358	0.1304347813	0.3086229861
93D45914-C99A-47FB-BD55-17FD1DD97C4E	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	3	N	895	175	364	88	201	75	NA	42	25	707.3095680288	0.1162790731	0.3209347427
BDAA2C2E-96C1-49C3-8DB9-3DD8B42A735B	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	3	N	764	178	353	88	192	73	NA	42	25	651.4997144226	0.1428571492	0.3276396692
5C07DE0D-F7A0-4CE9-9FA3-DC513E1E1B35	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	6.5	N	817	162	349	90	188	71	NA	43	25	608.4469022452	0.1428571492	0.3211643398
DB735500-DF9F-468C-835D-AC13F2BCDE1C	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	6.5	N	809	169	349	89	190	70	NA	40	25	631.5948842995	0.150000006	0.3221476972
FA68A936-A1F2-418B-B16C-3BEB805DB174	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	6.5	N	834	166	349	87	190	72	NA	42	25	615.8607354943	0.1162790731	0.3232454658
2D8F19EF-22BC-4C48-BA1D-AF84B83BD577	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7	N	926	172	361	89	199	73	NA	42	27	701.9123033584	0.1395348907	0.3570542336
805741EB-0E83-4389-B33E-E46073FB5D28	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7	N	820	165	357	88	198	71	NA	48	28	656.6456569633	0.1428571492	0.3424078822
B1213603-3DE7-4F5C-B6B4-AC86DB637031	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7	N	848	163	360	88	200	72	NA	43	25	672.4288067622	0.1190476194	0.337138474
0C80EA02-02CF-4550-9925-95A016F65F29	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7.5	N	838	169	353	85	196	72	NA	41	25	693.1856997971	0.1190476194	0.3271717727
6C13F12C-4C60-4473-B63D-8D6462817B48	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7.5	N	827	169	354	86	197	71	NA	45	27	701.5610786949	0.095238097	0.3282580972
C2A5652D-03D5-4F73-B0C7-DEE2EC3A9582	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7.5	N	825	169	350	87	192	71	NA	42	24	671.6416426944	0.0930232555	0.3326559365
2B4E3DDE-64F9-4716-B4AD-BF5C2BEB4BB6	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	8	N	828	173	360	87	200	73	NA	49	29	652.5649380403	0.1190476194	0.350189656
C2185386-BBA6-486A-9151-4B8CCB357499	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	8	N	843	169	362	88	202	72	NA	45	26	666.6426896633	0.1627907008	0.3445224464
CB78EE8F-C053-4C0A-9217-75AF4E711B8A	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	8	N	740	178	361	86	201	74	NA	44	26	641.4944893349	0.1590909064	0.3597441018
6E5CF798-896E-4D72-9A46-FF5B91F310B0	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12	N	820	177	354	87	193	74	NA	43	24	695.6897432817	0.1190476194	0.3083669841
8CC7467F-89EF-41A2-A9FF-E68257214410	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12	N	821	175	358	90	194	74	NA	42	26	675.9866622082	0.1162790731	0.2917815745
EE0982B7-031B-4952-B66C-32EC8AC4E3D1	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12	N	827	173	357	89	195	73	NA	41	25	696.5148890913	0.097560972	0.2924575508
1E10D6C0-0FA9-4D91-8074-4CD43507E3EF	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12.5	N	902	176	373	88	210	75	NA	44	27	699.8884436372	0.1627907008	0.326113224
39FECAC3-640A-418C-BCB5-6DDB39B211B9	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12.5	N	884	177	372	89	208	75	NA	43	26	709.8683669422	0.113636367	0.3336740732
B4601213-18F2-4581-ADC2-2B1561186D47	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12.5	N	901	176	370	89	205	76	NA	43	28	694.0798974913	0.1395348907	0.3367034793
3A26CFF6-2999-4E37-8C38-B306170B6641	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13	N	852	172	365	89	203	73	NA	42	26	679.9804271342	0.1428571492	0.3341845572
652BF38B-3B39-490F-B19A-251EA1EADDA9	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13	N	900	172	367	89	203	75	NA	44	26	675.2733509509	0.1304347813	0.3430483341
E16424BE-CA0E-4373-891B-BE95BAF2B93D	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13	N	846	169	367	90	203	74	NA	44	25	659.1225138328	0.1162790731	0.3420596719
78CF8010-BA41-4B5A-BAB9-2F1DA2BE5909	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13.5	N	953	182	365	90	201	74	NA	44	26	682.4552257186	0.1086956486	0.3207535148
82A3A384-7D39-4936-BB4A-639AC3C65031	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13.5	N	803	177	365	91	199	75	NA	44	27	640.3238798473	0.125	0.3610120714
AAD709BF-DD7B-4A31-A736-6F33F05886E5	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13.5	N	873	169	363	90	200	73	NA	45	27	617.2663314415	0.1395348907	0.3254809976
9BA5E798-9ADD-4921-AC74-4AC4D71D8BCE	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	24	N	800	182	355	87	196	72	NA	46	26	707.6551890055	0.1428571492	0.3244338036
D11820F8-EAB5-43CD-87F7-75B7A16BA9C5	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	24	N	814	183	357	88	197	72	NA	48	26	681.5015229962	0.1627907008	0.3371565342
E02BD6B0-EF99-41F2-9147-573A96F75712	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-4-DOSING	Placebo	NA	NA	NA	NA	NA	NA	24	N	738	179	353	87	194	72	NA	46	26	661.1774208371	0.1590909064	0.3167693019
25338715-28F1-42EF-BFF6-A6000E0A45CE	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	929	184	387	91	219	77	NA	46	27	664.970853235	0.1521739066	0.3850560784
814C8ED2-1D86-4390-96CD-04224F7A12D2	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	907	185	382	90	216	76	NA	44	27	666.0761674097	0.1739130467	0.3809591234
A8050141-DE3D-498D-90FB-04BCE36FB424	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	902	186	384	89	219	76	NA	44	27	672.8611016663	0.1627907008	0.3656657338
2A6D280B-8F7F-4055-A151-B70E3DBCE6FB	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	1.5	N	725	187	353	89	193	71	NA	43	24	631.0723616581	0.1666666716	0.314065069
3D5A4DF3-A308-4813-B11B-9097CC29653F	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	1.5	N	777	189	355	89	194	72	NA	42	26	643.5617441407	0.1521739066	0.327931881
C65F461E-F79C-4F79-B4EA-FCCA4242820E	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	1.5	N	846	190	357	88	197	72	NA	42	25	666.7164199329	0.1627907008	0.3278119564
3935A21A-0190-4390-AC57-A8CB16974026	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	2	N	885	176	363	87	204	72	NA	46	28	667.3911807382	0.1428571492	0.3432518244
80F98A11-60FE-41BB-84BF-82040D92B241	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	2	N	778	188	361	89	199	73	NA	47	29	643.2577788022	0.1333333403	0.3403884172
82CC7E5E-5A69-4107-99D3-AF2B8B2F31EA	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	2	N	840	193	361	88	200	73	NA	48	27	665.2107452001	0.1428571492	0.3298697174
442A3738-5074-4EA6-A754-714E8BEC4C6D	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	2.5	N	922	176	372	88	211	73	NA	47	29	697.8850558681	0.1162790731	0.3475066125
8747E2E7-19C0-4E7D-9FED-F063AC4414F5	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	2.5	N	815	190	359	88	199	72	NA	41	25	667.0028194669	0.1333333403	0.3223610222
C453375B-D606-4D57-BE2C-73544744DC74	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	2.5	N	859	175	368	88	207	73	NA	43	25	688.7865569595	0.1162790731	0.3255072534
54CF559E-A03C-4371-9167-3A7133F0095C	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	3	N	828	189	360	87	197	76	NA	42	25	676.2840001599	0.1304347813	0.3256503642
78F4C91C-C91D-438B-A88A-1B24F0B79CA3	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	3	N	706	183	355	89	191	75	NA	44	26	591.6785823082	0.1590909064	0.3296965659
99FA31E9-4C4C-468B-9DFA-80038965CC0A	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	3	N	942	184	362	87	200	75	NA	42	27	703.376699506	0.1162790731	0.3137630522
6087D66C-6598-4D1A-9202-FC191104F21E	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	276	NA	NA	NA	NA	NA	6.5	N	776	182	357	91	190	76	NA	47	31	527.8303027877	0.113636367	0.3738880455
ADDB8CA2-84DE-4663-B2D9-033993BED334	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	276	NA	NA	NA	NA	NA	6.5	N	832	179	360	91	194	75	NA	46	27	568.5816220352	0.1190476194	0.3745712936
EFEB8134-D6E9-4691-AA11-48F277D4F914	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	276	NA	NA	NA	NA	NA	6.5	N	805	185	356	90	190	76	NA	48	28	552.3753225754	0.1363636404	0.3723347187
2FABE25B-FE8E-4CD5-ABD8-ED03D4E8E4C7	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	502	NA	NA	NA	NA	NA	7	N	811	183	368	90	201	77	NA	51	31	546.844193895	0.1489361674	0.3969393969
98E03004-2143-4E90-A2F1-2DB5B4F94815	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	502	NA	NA	NA	NA	NA	7	N	880	176	373	90	207	76	NA	50	30	551.0163126334	0.1363636404	0.3932667971
B41C7E65-601A-4626-8707-C070C2016EDF	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	502	NA	NA	NA	NA	NA	7	N	958	173	380	90	213	77	NA	48	30	558.43108622	0.1489361674	0.4089237154
4CD03FE5-B5A8-4C37-B134-1F0C05B4E4C5	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	589	NA	NA	NA	NA	NA	7.5	N	852	188	373	89	206	78	NA	47	30	590.838183445	0.1363636404	0.3851950467
533353ED-C3FC-4D6B-8C8F-077AAABAE39A	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	589	NA	NA	NA	NA	NA	7.5	N	852	182	367	87	206	74	NA	46	28	592.0440845398	0.1276595742	0.3795706928
BAC5250B-D07A-4062-9A2D-7C04FCB32B2F	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	589	NA	NA	NA	NA	NA	7.5	N	811	188	369	88	205	76	NA	47	29	586.8871922113	0.1590909064	0.377689153
184A118A-E6FE-4DA1-801E-AA46A0D1DF63	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	743	NA	NA	NA	NA	NA	8	N	721	185	368	89	199	80	NA	53	30	545.1406619158	0.2083333284	0.396930486
A9BE2E6E-433D-4353-892D-76F24115070B	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	743	NA	NA	NA	NA	NA	8	N	815	174	377	87	211	79	NA	50	30	588.8312955848	0.1818181872	0.3850415647
BA6098DE-FA24-4DA3-AE74-9CAC3B521E1C	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	743	NA	NA	NA	NA	NA	8	N	822	184	377	90	209	78	NA	50	28	618.1251793368	0.1875	0.4002584815
409578ED-00D6-4AFF-ABD7-20F8D406FFC6	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	1830	NA	NA	NA	NA	NA	12	N	851	174	407	93	227	87	NA	67	37	491.3322966394	0.3829787374	0.4610273838
5C1DC225-9EE6-431A-AAFC-C1EC4DBE67CB	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	1830	NA	NA	NA	NA	NA	12	N	820	176	403	93	217	93	NA	65	42	477.2921071663	0.3137255013	0.4531187415
61F184FE-DB09-41E4-80F3-5030FA8B5041	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	1830	NA	NA	NA	NA	NA	12	N	843	176	407	92	226	89	NA	66	36	499.2647034605	0.3829787374	0.4608500302
34553089-6A06-498C-9BFC-268A6ADBE0DB	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	1870	NA	NA	NA	NA	NA	12.5	N	934	185	401	91	224	86	NA	64	37	554.9499888598	0.2599999905	0.4528194368
3F02AF5D-6D90-4F19-B279-BA902A6C5655	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	1870	NA	NA	NA	NA	NA	12.5	N	750	185	402	90	228	84	NA	77	33	452.2274051091	0.6086956263	0.4776668847
794D245B-8003-4AF7-B36D-EFBCF33AE26B	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	1870	NA	NA	NA	NA	NA	12.5	N	785	182	407	91	230	86	NA	75	35	484.4165030329	0.4893617034	0.469424516
02417A9D-DA30-4DF5-B681-638AC6D50790	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	2030	NA	NA	NA	NA	NA	13	N	791	183	402	89	226	87	NA	77	35	474.3596490469	0.4199999869	0.4781192243
44DCC04E-DEC1-4A1F-AFDB-DF924FADC358	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	2030	NA	NA	NA	NA	NA	13	N	833	185	404	90	228	86	NA	72	36	506.7991656111	0.4117647111	0.4693810046
E8BC5639-35A0-403D-8D0A-C4A234143F86	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	2030	NA	NA	NA	NA	NA	13	N	819	187	402	90	226	86	NA	69	36	512.1871856048	0.3541666567	0.4630546868
8EAC834C-CFB1-427F-8677-539C1652864D	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	1800	NA	NA	NA	NA	NA	13.5	N	852	186	395	90	216	89	NA	68	37	512.0296157782	0.2800000012	0.448182106
C04D082D-04B1-477C-A154-12BB840F4531	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	1800	NA	NA	NA	NA	NA	13.5	N	852	177	398	90	222	86	NA	65	36	520.092266464	0.2941176593	0.4596452415
EF6093B9-8644-4971-A741-0F6A54DE4EE6	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	1800	NA	NA	NA	NA	NA	13.5	N	891	186	396	90	218	88	NA	64	37	540.2378154852	0.2352941185	0.4523801804
0E7BEA0E-BF8F-48D4-9C1D-DB711CB183E2	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	24	N	756	171	360	87	196	77	NA	56	31	542.870209198	0.2093023211	0.3625422418
6DAA4B98-1D28-469C-BCF2-2D713103965A	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	24	N	734	167	358	88	195	75	NA	50	28	526.7913371468	0.2142857164	0.3609088063
71B0423C-ECEE-4F78-9E6B-017E0C3D92A2	2002	F	30	165	74.2	107.67	72.67	WHITE	NOT HISPANIC OR LATINO	C-B-D-E-A	PERIOD-5-DOSING	Dofetilide	NA	NA	NA	NA	NA	NA	24	N	733	176	359	87	197	75	NA	51	27	518.9318900003	0.2045454532	0.3663135469
1A5BD89F-35F3-4CE2-9CAF-83E54287EA35	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	956	124	418	91	243	84	NA	43	30	536.9547034015	0.1458333284	0.4403907359
38967015-4C37-439C-A8A8-9CD14C4C0FFA	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	945	123	417	91	243	83	NA	43	29	523.3966297371	0.1304347813	0.4494988024
3C1189A8-4962-46AB-BE8A-A80700A3B834	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	-0.5	Y	955	126	413	88	243	82	NA	42	29	525.980633746	0.1555555612	0.4289313257
A947185D-6DE1-4099-9C76-C76050295146	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	1370	NA	NA	NA	NA	1.5	N	961	121	384	90	216	78	NA	39	27	577.1951079903	0.1041666642	0.3961594403
B191F6FE-CA57-4511-8DE5-D3E534061841	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	1370	NA	NA	NA	NA	1.5	N	957	124	386	90	216	80	NA	40	25	562.468801323	0.1276595742	0.389423728
CAA1B59F-BFA6-4744-A905-011BF6A79672	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	1370	NA	NA	NA	NA	1.5	N	945	120	383	87	217	79	NA	41	27	553.0626845096	0.1590909064	0.3950861096
296F15EF-11DB-4389-A5CF-7BBCFB31DC51	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	1480	NA	NA	NA	NA	2	N	948	122	389	91	218	80	NA	40	26	578.7091873003	0.1489361674	0.3987456858
A5FB23C2-A215-4829-A813-AA43913ADDA3	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	1480	NA	NA	NA	NA	2	N	961	129	387	90	216	81	NA	41	26	565.0635361555	0.1777777821	0.4034622908
EB2F7719-5FF3-4ED5-BC9B-7B835A6D4F8D	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	1480	NA	NA	NA	NA	2	N	975	116	387	86	222	79	NA	40	27	588.2445063101	0.1777777821	0.3906058073
13C50D7E-E2B4-4BF8-AC19-C34F78EAE69E	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	1290	NA	NA	NA	NA	2.5	N	987	134	392	87	225	80	NA	40	27	587.1610154377	0.1458333284	0.4208992124
8FD58CDA-8286-421B-8062-A45437ED7EBE	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	1290	NA	NA	NA	NA	2.5	N	1005	132	396	89	225	82	NA	41	26	594.5659287993	0.1276595742	0.4192812741
EFD27D42-597B-4F00-9948-27DE02BC9A40	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	1290	NA	NA	NA	NA	2.5	N	1008	131	397	91	225	81	NA	41	26	586.7991118064	0.1489361674	0.4300764799
7A22BD71-ABC0-4DAC-BB85-65123E1C03FC	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	1090	NA	NA	NA	NA	3	N	924	107	380	85	216	79	NA	43	27	564.5398043269	0.1777777821	0.4178496599
C493586C-D768-435A-9C59-9632FCAA9BBF	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	1090	NA	NA	NA	NA	3	N	927	108	377	85	214	78	NA	42	27	544.5840483766	0.1914893687	0.401743114
E2768286-FA75-40DC-94B0-67CEFD3272BA	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	1090	NA	NA	NA	NA	3	N	964	107	382	87	217	78	NA	42	26	587.9320650008	0.1666666716	0.413300842
3030271B-2071-4840-881A-2AA16EB57CCD	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	124	2270	NA	NA	NA	NA	6.5	N	861	132	386	90	214	82	NA	45	29	434.0159418587	0.1304347813	0.3779783249
3BE54C73-3E8B-46B5-ADCD-30D9C40D71E1	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	124	2270	NA	NA	NA	NA	6.5	N	891	133	387	88	217	82	NA	45	30	439.5943472954	0.1875	0.4227744639
4E098B39-C072-46B8-B934-869753F0FB51	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	124	2270	NA	NA	NA	NA	6.5	N	917	132	390	90	216	84	NA	45	31	454.3573217483	0.1739130467	0.414431572
19AEFCC7-A6F2-4363-9663-CADA4D13B71C	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	316	2330	NA	NA	NA	NA	7	N	804	129	376	87	209	80	NA	47	31	400.7313429887	0.2666666806	0.4079479277
A889A458-0A07-4D04-B6D6-209629E4BF76	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	316	2330	NA	NA	NA	NA	7	N	889	130	389	87	215	87	NA	50	30	419.6833403053	0.1666666716	0.4074693024
EBEFE29E-8C9F-4501-A59B-B768942EC9A9	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	316	2330	NA	NA	NA	NA	7	N	904	116	384	84	218	82	NA	47	32	436.2477341011	0.1739130467	0.4103599489
04BF89AD-F818-4CFB-9B76-C094D3153FD5	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	411	2320	NA	NA	NA	NA	7.5	N	865	111	385	85	221	79	NA	46	31	437.2697640646	0.1632653028	0.4117658138
3114E7B5-D39B-4A55-BAEC-4380F5862BFB	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	411	2320	NA	NA	NA	NA	7.5	N	900	111	383	82	221	80	NA	47	29	462.4152541384	0.1836734712	0.4256955385
3DCDFC87-683E-4BFE-B7FC-8553AEE778F7	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	411	2320	NA	NA	NA	NA	7.5	N	884	118	385	84	223	78	NA	49	29	441.13547366	0.1914893687	0.4259948134
4BDF8C09-C599-424D-86F8-AA67718F54ED	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	640	1570	NA	NA	NA	NA	8	N	921	111	396	84	231	81	NA	47	30	500.4099803174	0.2340425551	0.442640692
6D638DBD-14DC-4271-9BB2-9C4EFD1852B1	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	640	1570	NA	NA	NA	NA	8	N	865	128	401	89	229	83	NA	47	31	468.1530075135	0.2244897932	0.4429514408
A38719AC-7714-465A-A222-1BA174ED7E39	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	640	1570	NA	NA	NA	NA	8	N	887	114	396	85	228	83	NA	49	29	484.0363398475	0.1914893687	0.4339401424
01FED0BA-CE10-4E74-A8A6-F049B6F5FD30	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	2310	2330	NA	NA	NA	NA	12	N	985	118	429	90	248	91	NA	59	31	457.0266038108	0.2549019754	0.4935346842
D12972E5-1BEA-44E7-A6B7-B340D5EB4C7E	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	2310	2330	NA	NA	NA	NA	12	N	951	121	427	88	248	91	NA	57	32	442.2364110711	0.2941176593	0.5001070499
E1B00A83-B4D0-4817-95D9-84E2F05C5A2A	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	2310	2330	NA	NA	NA	NA	12	N	989	121	431	88	251	92	NA	55	32	457.8868647764	0.3000000119	0.5012897849
2AAA28EA-ADA9-4393-88BC-05F40FDE2A61	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	2630	2840	NA	NA	NA	NA	12.5	N	947	131	428	88	250	90	NA	61	33	418.4094226523	0.387755096	0.5129588246
59564EBC-E928-4211-B361-2FC62520E14C	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	2630	2840	NA	NA	NA	NA	12.5	N	900	132	428	88	249	91	NA	61	33	411.1674587037	0.3137255013	0.49173522
AACADD98-D215-4C8B-BFAA-ACA07816D5AE	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	2630	2840	NA	NA	NA	NA	12.5	N	895	130	426	89	246	91	NA	59	33	415.1068154694	0.4042553306	0.4948382974
0D638130-EF85-41D1-B15E-C739CF15C16F	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	2650	2600	NA	NA	NA	NA	13	N	884	130	427	85	250	92	NA	65	34	376.9873854576	0.3125	0.4918597341
15A25A69-A624-4E08-832C-2A58FB2995A6	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	2650	2600	NA	NA	NA	NA	13	N	952	127	435	85	257	93	NA	65	37	390.5277423169	0.4042553306	0.5101635456
E5366491-F7C8-44B4-8A09-E0C7998FDBB3	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	2650	2600	NA	NA	NA	NA	13	N	957	110	431	83	257	91	NA	63	36	410.0986827417	0.3076923192	0.5142915249
038C126B-62C9-419E-A442-DBE4855885ED	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	2250	1940	NA	NA	NA	NA	13.5	N	964	122	439	87	260	92	NA	58	34	488.9619762955	0.3404255211	0.5232061148
787D6BDD-DC79-4E86-AF83-7E574CF5E4D0	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	2250	1940	NA	NA	NA	NA	13.5	N	951	121	437	89	254	94	NA	56	34	505.8280976722	0.4166666567	0.5113410354
F20124DE-E997-4027-B483-6867D627E0EC	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	2250	1940	NA	NA	NA	NA	13.5	N	942	134	440	90	255	95	NA	58	34	474.2558975829	0.3404255211	0.5101441741
78C991C0-AEAA-434A-999C-6D097BE9C1E2	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	946	118	427	89	254	84	NA	48	30	539.6980297584	0.2291666716	0.4871551394
8EFCE9EB-1C29-4F1E-9564-46FAD6C62067	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	908	131	430	90	254	86	NA	46	31	535.0530922315	0.2083333284	0.4767615199
94E9735F-5AAC-42CC-A4D0-8DFA7E58AF90	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-1-DOSING	Lidocaine + Dofetilide	NA	NA	NA	NA	NA	NA	24	N	904	117	416	90	244	82	NA	45	29	546.9611770817	0.1836734712	0.466979593
0E96FA1B-6363-41B8-A052-30B9C89D0D85	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	-0.5	Y	970	117	415	93	240	82	NA	42	29	553.5703827021	0.1489361674	0.4282510579
6F5CDA68-F666-447D-AFE9-CF8134CA88ED	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	-0.5	Y	958	125	410	92	238	80	NA	40	28	577.8025774915	0.1458333284	0.4336865842
8DDF7B5A-A334-45BF-BEED-015EDDF45B5F	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	-0.5	Y	946	123	411	89	244	78	NA	42	28	577.3118031108	0.1521739066	0.4306131303
4BAC93F1-9B8B-4168-893C-324C80967F4C	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	1.5	N	902	119	384	90	215	79	NA	39	28	531.433238032	0.1304347813	0.3783386648
B58107F4-95FA-4098-9630-0C317FD9070E	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	1.5	N	934	123	390	91	220	79	NA	40	29	538.0538979696	0.1739130467	0.3968063891
E6D647B2-DD87-40DA-9618-D51EEABEEC00	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	1.5	N	936	125	387	89	219	79	NA	40	28	545.9443747755	0.1555555612	0.3871501982
5D51160F-A41F-4F1B-8D62-87E34710DD75	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2	N	918	130	385	87	221	77	NA	41	26	515.8302476865	0.125	0.3940170407
8C844E70-501C-413E-8EFE-8FB128D7D358	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2	N	955	131	391	87	224	80	NA	41	27	538.1121771479	0.1521739066	0.4087424576
CE366698-8121-466E-8609-C3A6728B4BF9	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2	N	961	120	390	89	223	78	NA	40	27	536.7592849041	0.1458333284	0.3950012922
CC4B013E-5D3B-401D-8900-FFCB3D842849	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2.5	N	939	129	390	90	222	78	NA	39	27	555.1809135764	0.1063829809	0.3794105649
EECC42D6-EB1F-4A1F-9509-98C0C5692DD5	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2.5	N	961	124	392	89	226	77	NA	39	27	553.0181754511	0.1304347813	0.3807241619
FD0A8EB7-E752-4D4B-8814-AF865AA9794A	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	2.5	N	961	130	390	89	223	78	NA	38	26	547.7137141165	0.1333333403	0.3982279599
26FDF9FC-2DE6-49DB-BCE9-867F298BD960	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	3	N	1022	118	400	91	231	78	NA	40	28	616.0576065086	0.1199999973	0.4132846296
4B58666E-4C96-4010-8ECA-E1E1C6084E64	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	3	N	994	128	404	91	234	79	NA	41	28	597.0168071147	0.1276595742	0.4151992202
6B6F55C6-60EC-448B-BD0B-87069FF8B399	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	3	N	1010	124	399	91	231	77	NA	41	26	607.5024470583	0.125	0.4060582817
2402A348-1DBA-46C0-952F-349138D82F5B	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	6.5	N	897	126	392	89	221	82	NA	46	29	420.2761231875	0.1063829809	0.413900286
EEDB3C6F-E4B0-4413-A428-2A5A3C7C7FD4	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	6.5	N	867	113	390	87	224	79	NA	45	31	423.9982979028	0.1555555612	0.3941446245
F876E35F-1B53-43DB-AEFC-C8640099EF5D	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	6.5	N	900	126	396	89	225	82	NA	44	31	438.5607910032	0.1521739066	0.4013412893
0D88066B-3603-43C7-80F4-F53A1EE945BD	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7	N	940	113	395	89	225	81	NA	45	30	467.8182324259	0.1632653028	0.4133206904
1CC5D543-4A64-4F4C-8269-B9F561602009	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7	N	898	130	399	89	225	85	NA	43	32	464.2141948622	0.1458333284	0.3971950114
1F563505-2977-41AC-856C-0043EB6CFD28	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7	N	901	127	393	88	225	80	NA	46	31	440.947296954	0.200000003	0.40742746
179E5F90-5CE1-453A-90D8-92982CB85036	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7.5	N	875	113	391	87	226	78	NA	42	30	458.7824669652	0.1777777821	0.4029905498
4ACF9DD4-04BD-4A53-8B79-AB73645C80B7	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7.5	N	882	118	393	87	226	80	NA	43	31	460.9783747428	0.1521739066	0.3851764202
B4FC6D9E-FE52-457B-9E08-C2954C660395	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	7.5	N	883	130	398	88	227	83	NA	44	31	450.4648876558	0.1666666716	0.4016617835
7D20650D-36FE-4AC8-98CA-4A72B244EB9F	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	8	N	932	111	396	86	231	79	NA	41	30	542.5409049855	0.1276595742	0.4090636373
9A6F1B89-6C36-4AA3-9DEC-5095D3971A3B	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	8	N	927	127	397	87	229	81	NA	41	30	531.3782303879	0.1224489808	0.4117964208
D440411D-97EB-4A53-8618-CE5909EFAE65	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	8	N	940	119	394	87	227	80	NA	40	29	539.3156639541	0.1041666642	0.3902267218
0E15D8C0-9033-4608-9608-7728640B3390	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12	N	930	117	391	87	223	81	NA	42	29	500.6503667094	0.1555555612	0.4077860415
379E333C-7D66-4D6E-B2FF-F7CD244DDAD2	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12	N	906	117	394	91	222	81	NA	44	29	481.0702884204	0.1458333284	0.3993084729
BBF1E79E-78F8-4F5A-A43A-428B6231E6B9	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12	N	894	121	388	89	217	82	NA	41	28	475.1129449757	0.1086956486	0.3999244869
01C344CA-AD7B-419F-BBD5-9AAEAF36B95B	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12.5	N	997	116	398	89	230	79	NA	44	29	481.7407479159	0.1199999973	0.4148855805
7A54B399-C049-485B-9C51-E37C915653B8	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12.5	N	951	116	393	88	226	79	NA	41	29	498.4509522693	0.1276595742	0.401575923
9A1AA6AD-E963-47A7-973B-B8C9369CA4A3	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	12.5	N	954	116	394	88	227	79	NA	42	30	488.2234650628	0.1224489808	0.4045287967
294F7A38-ADC1-4F5F-9E97-30EBF62AD920	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13	N	933	121	396	88	229	79	NA	43	28	510.6700399018	0.1666666716	0.407541573
50FA2C71-3244-4879-9997-64886C11DE40	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13	N	949	113	399	89	229	81	NA	42	30	506.6298134075	0.1458333284	0.4219912589
C176B654-B6B5-4926-BE03-76A5FC783706	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13	N	900	125	396	87	228	81	NA	43	28	492.6604930577	0.1458333284	0.427642107
612F2D0A-E16F-4D0D-9100-004D437F52CB	2003	F	23	172	69.3	111	58.33	WHITE	NOT HISPANIC OR LATINO	B-E-C-A-D	PERIOD-2-DOSING	Placebo	NA	NA	NA	NA	NA	NA	13.5	N	948	118	399	88	230	81	NA	42	29	520.5152710891	0.1555555612	0.4108429849

Only the first 500 rows are shown. Click here to download the complete file.